I am a
Home I AM A Search Login

Papers of the Week


2022 Feb 16


BMJ Open


12


2

Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations.

Authors

Kaneko K, Prieto-Alhambra D, Jacklin C, Bosworth A, Dickinson S, Berry S, McAteer H, Taylor PC
BMJ Open. 2022 Feb 16; 12(2):e050949.
PMID: 35172995.

Abstract

To investigate the perceptions and experiences of people with specific immune-mediated inflammatory diseases during the process of switching from Humira to biosimilar adalimumab.